References - Therapeutic Strategies in Cancer Biology and Pathology - page 201

Ceppi, P., Mudduluru, G., Kumarswamy, R., Rapa, I., Scagliotti, G.V., Papotti, M., et al.,
2010. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant
phenotype in non-small cell lung cancer. Mol. Cancer Res. 8, 1207-1216.
Chamorro-Jorganes, A., Araldi, E., Penalva, L.O.F., Sandhu, D., Fernandez-Hernando, C.,
Suarez, Y., 2011. MicroRNA-16 and microRNA-424 regulate cell-autonomous angio-
genic functions in endothelial cells via targeting vascular endothelial growth factor recep-
tor-2 and fibroblast growth factor receptor-1. Artherioscl. Thromb. Vasc. Biol. 31, 2595.
Chan, J.A., Krichevsky, A.M., Kosik, K.S., 2005. MicroRNA-21 is an antiapoptotic factor in
human glioblastomacells. Cancer Res. 65, 6029-6033.
Chan, K.T., Lung, M.L., 2004. Mutant p53 expression enhanced drug resistance in a hepato-
cellular carcinoma cell line. Cancer Chemother. Pharmacol. 53, 519-526.
Chan, S.Y.Y., To, K.F., Leung, S.F., Yip, W.W.L., Mak, M.K.F., Chung, G.T.Y., et al., 2010.
14-3-3 sigma expression as a prognostic marker in undifferentiated nasopharyngeal carci-
noma. Oncol. Rep. 24, 949-955.
Chang, C.J., Hsu, C.C., Chang, C.H., Tsai, L.L., Chang, Y.C., Lu, S.W., et al., 2011a. Let-7d
functions as novel regulator of epithelial-mesenchymal transition and chemoresistant
property in oral cancer. Oncol. Rep. 26, 1003-1010.
Chang, C.J., Chao, C.H., Xia, W., Yang, J.Y., Xiong, Y., Li, C.W., et al., 2011b. p53 regulates
epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
Nat. Cell. Biol. 13, 317-323.
Chang, H., Li, Q., Moraes, R.C., Lewis, M.T., Hamel, P.A., 2010. Activation of Erk by sonic
hedgehog independent of canonical hedgehog signalling. Int. J. Biochem. Cell. Biol. 42,
1462-1471.
Chang, J.T., Wang, H.M., Chang, K.W., Chen, W.H., Wen, M.C., Hsu, Y.M., et al., 2005.
Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC):
overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int. J.
Cancer 114, 942-949.
Chang, S., Wang, R.H., Akagi, K., Kim, K.A., Martin, B.K., Cavallone, L., et al., 2011c.
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat. Med.
17 1275-U308
Chang, T.C., Liu, C.C., Hsing, E.W., Liang, S.M., Chi, Y.H., Sung, L.Y., et al., 2012a. 14-
3-3 sigma regulates beta-catenin-mediated mouse embryonic stem cell proliferation by
sequestering GSK-3 beta. PLoS ONE 7, e40193.
Chang, T.H., Tsai, M.F., Su, K.Y., Wu, S.G., Huang, C.P., Yu, S.L., et al., 2011d. Slug confers
resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am. J. Resp.
Crit. Care Med. 183, 1071-1079.
Chang, Z.G., Wei, J.M., Qin, C.F., Hao, K., Tian, X.D., Xie, K., et al., 2012b. Suppression of
the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human
pancreatic cancer PANC-1 cells. Dig. Dis. Sci. 57, 1181-1189.
Chapman, E.J., Carrington, J.C., 2007. Specialization and evolution of endogenous small
RNA pathways. Nat. Rev. Genet. 8, 884-896.
Chatterjee, D., Bai, Y., Wang, Z., Beach, S., Mott, S., Roy, R., et al., 2004. RKIP sensi-
tizes prostate and breast cancer cells to drug-induced apoptosis. J. Biol. Chem. 279,
17515-17523.
Chauhan, D., Singh, A., Brahmandam, M., Podar, K., Hideshirna, T., Richardson, P., et al.,
2008. Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo
synergistic cytotoxicity in multiple myeloma. Blood 111, 1654-1664.
Che, N., Zhao, X.L., Sun, T., Zhao, X.M., Gu, Q., Dong, X.Y., et al., 2011. The role of Twist1
in hepatocellular carcinoma angiogenesis: a clinical study. Hum. Pathol. 42, 840-847.